Stivarga is the standard third-line treatment for metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
It is estimated that one-third of our country’s population has some form of these disorders
The drug, intended for chronic weight management alongside diet and exercise, is now under the FDA’s new CNPV expedited review pathway
The trial tested six injectable doses and three oral doses over as long as 36 weeks
The formulation is backed by over 80 clinical trials and 200 scientific publications
Roche will unveil the primary results from the phase III evERA Breast Cancer study evaluating giredestrant
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
Subscribe To Our Newsletter & Stay Updated
